Epigallocatechin-3-Gallate and PEDF 335 Peptide, 67LR Activators, Attenuate Vasogenic Edema, and Astroglial Degeneration Following Status Epilepticus

P2 × 7 receptor inhibits astroglial autophagy via regulating FAK-and PHLPP1/2-mediated AKT-s473 phosphorylation following kainic acid-induced seizures

PLPP/CIN-mediated Mdm2 dephosphorylation increases seizure susceptibility via abrogating PSD95 ubiquitination

PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats

Blockade of 67-kDa Laminin Receptor Facilitates AQP4 Down-Regulation and BBB Disruption via ERK1/2-and p38 MAPK-Mediated PI3K/AKT Activations

CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NF kappa B- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus

Deletion of P2X7 Receptor Decreases Basal Glutathione Level by Changing Glutamate-Glutamine Cycle and Neutral Amino Acid Transporters

PDI-Mediated Reduction of Disulfide Bond on PSD95 Increases Spontaneous Seizure Activity by Regulating NR2A-PSD95 Interaction in Epileptic Rats Independent of S-Nitrosylation

TRPC6-Mediated ERK1/2 Activation Increases Dentate Granule Cell Resistance to Status Epilepticus via Regulating Lon Protease-1 Expression and Mitochondrial Dynamics

CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-kappa B p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus